Siril S. Bakke
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A novel TIRAP-MyD88 inhibitor blocks TLR7- and TLR8-induced type I IFN responses.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 02, 2025
Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo.
Journal: Life science alliance
Published: May 16, 2023
Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction.
Journal: International journal of molecular sciences
Published: December 02, 2021
Increased Glycolysis and Higher Lactate Production in Hyperglycemic Myotubes.
Journal: Cells
Published: August 28, 2019
Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis.
Journal: Atherosclerosis
Published: November 13, 2018
Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children.
Journal: Molecular nutrition & food research
Published: September 19, 2018
Loss of perilipin 2 in cultured myotubes enhances lipolysis and redirects the metabolic energy balance from glucose oxidation towards fatty acid oxidation.
Journal: Journal of lipid research
Published: August 05, 2017
Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 24, 2017
Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 14, 2015
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
Journal: Science translational medicine
Published: October 11, 2015
Last Updated: 09/26/2026